Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

Written by Emily J. Thompson, Senior Investment Analyst

RSLS%

Source: Newsfilter

Updated: Aug 14 2025

0mins

Source: Newsfilter

Merger Announcement: Vyome Therapeutics has completed its merger with ReShape Lifesciences, and the new entity will operate under the name Vyome Holdings, Inc. starting August 15, 2025, with the trading symbol "HIND."
Company Focus and Future Outlook: Vyome aims to leverage its clinical-stage assets to address immuno-inflammatory conditions while maintaining a cost-efficient operation across the US-India innovation corridor, although future performance is subject to uncertainties and risks.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

About the author

Top News

Ford Announces $19.5B EV Restructuring Charges

Fed Cuts Interest Rates Amid Economic Concerns

SpaceX Targets $800 Billion Valuation in Secondary Sale

U.S. Consumer Sentiment Slightly Improves in December

Related Articles

36Kr Successfully Hosts WISE 2025 Conference, Attracting Over 500 Million Views

OptimizeRx Expands POC Network with Four New Partner Agreements, Increasing NPI Reach by 37%

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch